| Peer-Reviewed

Short Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass in Super Obese Patients: Randomized Clinical Trial

Received: 1 August 2021     Accepted: 12 August 2021     Published: 27 August 2021
Views:       Downloads:
Abstract

Background: One anastomosis gastric bypass (OAGB) has several apparent advantages over Roux-En-Y Gastric Bypass (RYGB). However, symptomatic biliary reflux and its potential risks have prevented its widespread adoption. The aim of this study was to assess the short term outcomes of LOAGB in comparison to LRYGB in treatment of patients with super obesity regarding weight loss, resolution/improvement of co-morbidities and impact on patients’ quality of life (QoL). Methods: One hundred adult patients with super obesity were randomly divided into 2 matched groups, 50 patients each; group I underwent LRYGB and group II underwent LOAGB. Results: The operative time was significantly longer in LRYGB (176.4±27.29 vs. 110.5±14.13 minutes, p<0.05). The frequency and severity of the early postoperative complications were comparable between both groups. No mortality or re-admission was reported in both groups. There are no patients lost to follow-up. Although, the mean Excess weight loss percent (EWL%) was 57% vs 64.7% and 69.7% vs 75.5% at one and two years follow-up in group I and II respectively, the differences were statistically insignificant. T2DM remission/improvement rates at 12th month were 88.9% and 94.1% in group I and II respectively without a statistically insignificant difference. In comparison to the preoperative Qol score, the postoperative score showed a statistically significant improvement (from 0.31 to 6 and from 0.41 to 6.32 in group I and II respectively). Conclusions: LOAGB had a shorter operative time and a tendency towards a higher EWL%, a better remission of obesity-related comorbidities and improvement in the patients QoL with comparable short term operative and postoperative complications. Thus, LOAGB can be considered an acceptable alternative to LRYGB in management of super obese patients.

Published in Journal of Surgery (Volume 9, Issue 4)
DOI 10.11648/j.js.20210904.22
Page(s) 209-215
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Laparoscopic Roux-en-Y Gastric Bypass, Laparoscopic One Anastomosis Gastric Bypass, Super Obesity

References
[1] Sjöström L. Review of the key results from the Swedish obese subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013; 273: 219–34.
[2] Marmuse JP and Parenti LR. Gastric bypass, principles, complications, and results. Visc Surg. 2010; 147 (5): 31–7.
[3] Mahawar KK, Jennings N, Brown J, Balupuri S, Small PK. Minigastric bypass: systematic review of a controversial procedure. Obes Surg. 2013; 23: 1890–8.
[4] Oria HE, Moorehead MK: Bariatric analysis and reporting outcome system (BAROS). Obes Surg. 1998; 8 (5): 487-99.
[5] Still C, Wood G, Benotti P, Petrick A, Gabrielsen J, Strodel W, et al. A probability score for preoperative prediction of type 2 diabetes remission following RYGB surgery. Lancet Diabetes Endocrinol. 2014); 2 (1): 38–45.
[6] Alkhalifah N, Lee WJ, Hai TC, Ser KH, Chen JC, Wu CC. 15-year experience of laparoscopic single anastomosis (mini) gastric bypass: comparison with other bariatric procedures. Surg Endosc. 2018; 32: 3024–31.
[7] Rheinwalt KP, Plamper A, Rückbeil M, Kroh A, Neumann UP, Ulmer TF. al. One anastomosis gastric bypass–mini-gastric bypass (OAGB-OAGB) versus Roux-en-Y Gastric Bypass (RYGB) - a mid-term cohort study with 612 patients. Obes Surg. 2020; 30: 1230–40.
[8] Jammu GS, Sharma R. A 7-Year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes surg. 2016; 26: 926–32.
[9] Mahawar KK, Parmar C, Carr WR, Jennings N, Schroeder N, Small PK. Impact of biliopancreatic limb length on severe protein–calorie malnutrition requiring revisional surgery after one anastomosis (mini) gastric bypass. J Min Access Surg 2018; 14: 37-43.
[10] Georgiadou D, Sergentanis TN, Nixon A, Diamantis T, Tsigris C, Psaltopoulou T. Efficacy and safety of laparoscopic mini-gastric bypass. A systematic review. Surg Obes Relat Dis. 2014; 10: 984–91.
[11] Mahawar K, Kumar P, Carr W, Jennings N, Schroeder N, Balupuri S. Current status of mini-gastric bypass. J Minim Access Surg. 2016 (a); 12 (4): 305–10.
[12] Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors and patient presentation: a systematic review. Obes Surg. 2014; 24 (2): 299–309.
[13] Coblijn U, Lagarde S, de Castro S, Kuiken SD, Wagensveld BA. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes surg. 2015; 25: 805–11.
[14] Robert M, Espalieu P, Pelascini P, Caiazzo R, Sterkers A, Khamphommala L, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019; 393: 1299–309.
[15] Parmar C, Abdelhalim M, Mahawar K, Boyle M, Carr W, Jennings N, et al. Management of super–super obese patients: comparison between one anastomosis (mini) gastric bypass and Roux-en-Y gastric bypass. Surg Endosc. 2017; 31: 3504–9.
[16] Kruschitz R, Luger M, Kienbacher C, Trauner M, Klammer C, Schindler K, et al. The effect of Roux en Y vs. omega-loop gastric bypass on liver, metabolic parameters, and weight loss. Obes Surg 2016; 26: 2204–12.
[17] Lee WJ, Yu PJ, Wang W, Chen T, Wei P, Huang M. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. a prospective randomized controlled clinical trial. Ann Surg 2005; 242: 20–8.
[18] Spivak H, Munz Y, Rubin M, Raz I, Shohat T, Blumenfeld O. Omega-loop gastric bypass is more effective for weight loss but negatively impacts liver enzymes: a registry-based comprehensive first-year analysis. Surg Obes. Relat. Dis. 2018; 14: 175–80.
[19] Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Ygastric bypass for morbid obesity: a meta-analysis. Clinical Obesity. 2018; 8: 159–69.
[20] Disse E, Pasquer A, Espalieu P, Poncet G, Gouillat C, Robert M. Greater weight loss with the omega loop bypass compared to the Roux-en-Y gastric bypass: a comparative study. Obes Surg 2014; 24: 841–6.
[21] Mahawar K, Kumar P, Parmar C, Graham Y, Carr W, Jennings N, et al. Small bowel limb lengths and Roux en Y gastric bypass: a systematic review. Obes Surg. 2016 (b); 26: 660-71.
[22] Lee WJ, Ser KH, Lee YC, Tsou J, Chen S, Chen J. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012; 22 (12): 1827-34.
[23] Musella M A, Susa F, Greco M, De Luca M, Manno E, Di Stefano C, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014; 28: 156–63.
[24] Noun R, Skaff J, Riachi E, Daher R, Antoun N, Nasr M. One thousand consecutive mini-gastric bypass: Short- and long-term outcome. Obes Surg. 2012; 22: 697–703.
[25] Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses- first study from Indian subcontinent. Obes Surg. 2014; 24: 1430–5.
[26] Chevallier JM, Arman GA, Guenzi M, Rau C, Bruzzi M, Beaupel N, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015; 25: 951–8.
[27] Almalki OM, Lee WJ, Chong K, Ser KH, Lee YC, Chen SC. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux en- Y versus single anastomosis gastric bypass. Surg Obes Relat Dis 2018; 14 (4): 509-15.
[28] Ahuja A, Tantia O, Chaudhuri, Khanna S, Seetharamaiah S, Majumdar K, et al. Predicting remission of diabetes post metabolic surgery: a comparison of ABCD, diarem, and DRS scores. Obes Surg. 2018; 28: 2025–31.
[29] Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013; 81 (13): 1159-65.
[30] Handley JD, Baruah BP, Williams DM, Horner M, Barry J, Stephens J. Bariatric surgery as a treatment for idiopathic intracranial hypertension: A systematic review. Surg Obes Relat Dis. 2015; 08: 497.
[31] Campos GM, Rabl C, Roll GR, Peeva S, Prado K, Smith J, et al. Better weight loss, resolution of diabetes, andquality of life for laparoscopic gastric bypass vs banding: results of a 2-cohortpair-matched study. Arch Surg. 2011; 146: 149–55.
[32] Al Harakeh A, Larson C, Mathiason M, Kallies K, Kothari S. BAROS results in 700 patients after laparoscopic Roux-en-Y gastric bypass with subset analysis of age, gender, and initial body mass index. Surg Obes Relat Dis. 2011; 7: 94–8.
[33] Biter LU, Buuren MM, Mannaerts GH, Apers J, Dunkelgrün M, Vijgen G. Quality of life 1 year after laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y Gastric bypass: a randomized controlled trial focusing on gastroesophageal reflux disease. Obes surg. 2017; 27: 2557–65.
[34] Peterli R, Wölnerhanssen BK, Vetter D, Vetter D, Nett P, Gass M, Borbély Y, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-Gastric bypass for morbid obesity—3-year outcomes of the prospective randomized swiss multicenter bypass or sleeve study (SM-BOSS). Ann Surg 2017; 265: 466–73.
Cite This Article
  • APA Style

    Mahmoud El Ghoneimy Abd El-Sadek, Ahmed Ibrahim Swelam, Hamdy Sedky Abdallah, Gamal Ibrahim Moussa, Osama Helmy El Khadrawy. (2021). Short Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass in Super Obese Patients: Randomized Clinical Trial. Journal of Surgery, 9(4), 209-215. https://doi.org/10.11648/j.js.20210904.22

    Copy | Download

    ACS Style

    Mahmoud El Ghoneimy Abd El-Sadek; Ahmed Ibrahim Swelam; Hamdy Sedky Abdallah; Gamal Ibrahim Moussa; Osama Helmy El Khadrawy. Short Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass in Super Obese Patients: Randomized Clinical Trial. J. Surg. 2021, 9(4), 209-215. doi: 10.11648/j.js.20210904.22

    Copy | Download

    AMA Style

    Mahmoud El Ghoneimy Abd El-Sadek, Ahmed Ibrahim Swelam, Hamdy Sedky Abdallah, Gamal Ibrahim Moussa, Osama Helmy El Khadrawy. Short Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass in Super Obese Patients: Randomized Clinical Trial. J Surg. 2021;9(4):209-215. doi: 10.11648/j.js.20210904.22

    Copy | Download

  • @article{10.11648/j.js.20210904.22,
      author = {Mahmoud El Ghoneimy Abd El-Sadek and Ahmed Ibrahim Swelam and Hamdy Sedky Abdallah and Gamal Ibrahim Moussa and Osama Helmy El Khadrawy},
      title = {Short Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass in Super Obese Patients: Randomized Clinical Trial},
      journal = {Journal of Surgery},
      volume = {9},
      number = {4},
      pages = {209-215},
      doi = {10.11648/j.js.20210904.22},
      url = {https://doi.org/10.11648/j.js.20210904.22},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20210904.22},
      abstract = {Background: One anastomosis gastric bypass (OAGB) has several apparent advantages over Roux-En-Y Gastric Bypass (RYGB). However, symptomatic biliary reflux and its potential risks have prevented its widespread adoption. The aim of this study was to assess the short term outcomes of LOAGB in comparison to LRYGB in treatment of patients with super obesity regarding weight loss, resolution/improvement of co-morbidities and impact on patients’ quality of life (QoL). Methods: One hundred adult patients with super obesity were randomly divided into 2 matched groups, 50 patients each; group I underwent LRYGB and group II underwent LOAGB. Results: The operative time was significantly longer in LRYGB (176.4±27.29 vs. 110.5±14.13 minutes, pth month were 88.9% and 94.1% in group I and II respectively without a statistically insignificant difference. In comparison to the preoperative Qol score, the postoperative score showed a statistically significant improvement (from 0.31 to 6 and from 0.41 to 6.32 in group I and II respectively). Conclusions: LOAGB had a shorter operative time and a tendency towards a higher EWL%, a better remission of obesity-related comorbidities and improvement in the patients QoL with comparable short term operative and postoperative complications. Thus, LOAGB can be considered an acceptable alternative to LRYGB in management of super obese patients.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Short Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass in Super Obese Patients: Randomized Clinical Trial
    AU  - Mahmoud El Ghoneimy Abd El-Sadek
    AU  - Ahmed Ibrahim Swelam
    AU  - Hamdy Sedky Abdallah
    AU  - Gamal Ibrahim Moussa
    AU  - Osama Helmy El Khadrawy
    Y1  - 2021/08/27
    PY  - 2021
    N1  - https://doi.org/10.11648/j.js.20210904.22
    DO  - 10.11648/j.js.20210904.22
    T2  - Journal of Surgery
    JF  - Journal of Surgery
    JO  - Journal of Surgery
    SP  - 209
    EP  - 215
    PB  - Science Publishing Group
    SN  - 2330-0930
    UR  - https://doi.org/10.11648/j.js.20210904.22
    AB  - Background: One anastomosis gastric bypass (OAGB) has several apparent advantages over Roux-En-Y Gastric Bypass (RYGB). However, symptomatic biliary reflux and its potential risks have prevented its widespread adoption. The aim of this study was to assess the short term outcomes of LOAGB in comparison to LRYGB in treatment of patients with super obesity regarding weight loss, resolution/improvement of co-morbidities and impact on patients’ quality of life (QoL). Methods: One hundred adult patients with super obesity were randomly divided into 2 matched groups, 50 patients each; group I underwent LRYGB and group II underwent LOAGB. Results: The operative time was significantly longer in LRYGB (176.4±27.29 vs. 110.5±14.13 minutes, pth month were 88.9% and 94.1% in group I and II respectively without a statistically insignificant difference. In comparison to the preoperative Qol score, the postoperative score showed a statistically significant improvement (from 0.31 to 6 and from 0.41 to 6.32 in group I and II respectively). Conclusions: LOAGB had a shorter operative time and a tendency towards a higher EWL%, a better remission of obesity-related comorbidities and improvement in the patients QoL with comparable short term operative and postoperative complications. Thus, LOAGB can be considered an acceptable alternative to LRYGB in management of super obese patients.
    VL  - 9
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • General Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • General Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • General Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • General Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • General Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • Sections